Fidelity Investments’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.59M | Sell |
|
|||||
|
2025
Q2 | $2.19M | Sell |
|
|||||
|
2025
Q1 | $4.5M | Sell |
|
|||||
|
2024
Q4 | $87.8M | Buy |
|
|||||
|
2024
Q3 | $284M | Buy |
|
|||||
|
2024
Q2 | $216M | Sell |
|
|||||
|
2024
Q1 | $332M | Buy |
|
|||||
|
2023
Q4 | $154M | Buy |
|
|||||
|
2023
Q3 | $115M | Sell |
|
|||||
|
2023
Q2 | $163M | Buy |
|
|||||
|
2023
Q1 | $173M | Buy |
|
|||||
|
2022
Q4 | $177M | Sell |
|
|||||
|
2022
Q3 | $145M | Buy |
|
|||||
|
2022
Q2 | $99.5M | Buy |
|
|||||
|
2022
Q1 | $164M | Sell |
|
|||||
|
2021
Q4 | $205M | Buy |
|
|||||
|
2021
Q3 | $138M | Buy |
|
|||||
|
2021
Q2 | $148M | Buy |
|
|||||
|
2021
Q1 | $180M | Buy |
|
|||||
|
2020
Q4 | $187M | Buy |
|
|||||
|
2020
Q3 | $69M | Buy |
|
|||||
|
2020
Q2 | $51M | Buy |
|